Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Either the symbol is incorrect or we do not track estimates for this company
Ranking History
Headlines
- Dutton Associates Announces Investment Opinion: Sinobiomed Speculative Buy Rating In Update Coverage By Dutton Associates
Oct 22, 2008 10:27 AM
- Sinobiomed Directors Confirm Hiring of New Chief Financial Officer
Oct 08, 2008 01:30 PM
- Sinobiomed Hires New Director of Strategic Development
Sep 03, 2008 09:31 AM
- Sinobiomed Retains CB Capital Partners As Financial Advisor to Maximize Shareholder Value
Aug 26, 2008 08:52 PM
- Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
Aug 26, 2008 01:15 PM
- Sinobiomed Applies for Two Chinese Patents and One International Patent
Aug 21, 2008 09:31 AM
- Sinobiomed Corporate Update
Aug 20, 2008 11:00 AM
- Sinobiomed Hires New Chief Financial Officer
Aug 13, 2008 11:01 AM
- Sinobiomed Secures New Funding to Spur Growth
Jul 30, 2008 11:13 AM
- Phase II Clinical Trial of Sinobiomed's Malaria Candidate Vaccine to Start in Q3
May 14, 2008 09:02 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
SOBM
|
Compare to S&P
|
| YTD |
-0.01 %
|
-0.01 %
|
| 4 Weeks |
14.81 %
|
35.93 %
|
| 12 Weeks |
-82.78 %
|
-73.25 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 100.00 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: 105.88 %
|
|
Sales Growth in Last Quarter: 1.16 %
|
|
|
